| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 164.68 |
| Category | Health |
| Net Assets | 160.40 Mil |
| Yield | 0.00% |
| Morningstar Risk | High |
| Morningstar Return | High |
- Last NAV update 5/17/2013 4:00 PM ET
| NA |
|---|
| The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. BiotechnologySM Index. The fund invests in securities and derivatives that the adviser believes, in combination, should have similar daily return characteristics as one and one-half times (1.5x) the daily return of the index. The index measures the performance of the biotechnology sector of the U.S. equity market. It is non-diversified. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 3.15% | 6.32% | 8.49% | 65.82% | 65.32% |
| Value ($) | 10,315.00 | 10,966.91 | 11,898.00 | 19,729.26 | 32,616.41 |
- Year to date performance as of 5/16/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | ProFunds |
| Fund Manager | Hratch Najarian |
| Tenure (Years) | 2 |
| Fund Status | Open |
| Minimum Initial Purchase | 15,000.00 |
| Minimum IRA Investment | 15,000.00 |
| Front Load | 0.00 |
| Expense Ratio | 1.72% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 11.03% |
| 3 Months | 46.23% |
| 1 Year | 111.97% |
| 3 Years* | 47.71% |
| 5 Years* | 25.37% |
- * Annualized returns
- Performance as of 5/16/2013 8:00 PM ET
| BIPIX | Health | |
|---|---|---|
| 5-Yr Return | 25.37% | 12.34% |
| Sharpe Ratio | 1.41 | 1.13 |
| Net Assets | 160.40 Mil | 504.34 Mil |
| Avg Market Cap | 30.59 Bil | 18.61 Bil |
| Avg P/E | 24.15 | 18.60 |
| Portfolio Turnover | 37 | 48 |
| Symbol | Value ($) |
|---|---|
| Stocks | 56.32% |
| Cash | 42.49% |
| Fixed Income | 0.00% |
| Other | 1.20% |
| NAME | % NET ASSETS |
|---|---|
| Amgen Inc | 10.13% |
| Gilead Sciences Inc | 9.23% |
| AbbVie Inc | 8.97% |
| Celgene Corporation | 6.48% |
| Biogen Idec Inc | 5.71% |
| Alexion Pharmaceuticals, Inc. | 2.83% |
| Regeneron Pharmaceuticals, Inc. | 2.03% |
| Life Technologies Corp | 1.72% |
| Vertex Pharmaceuticals | 1.49% |
| Biomarin Pharmaceutical, Inc. | 1.06% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
